Randomized phase 2 trial· 2021
Effect of Bimagrumab vs Placebo on Body Fat Mass Among Adults With Type 2 Diabetes and Obesity: A Phase 2 Randomized Clinical Trial
Heymsfield SB|Coleman LA|Miller R|Rooks DS|Laurent D|Petricoul O|Praestgaard J|Swan T|Frost M|Vitolins MZ
JAMA Network Open
- PubMed
- 33439265
- Evidence level
- strong
- Verification
- verified
Summary
A 48-week randomized phase 2 trial compared bimagrumab with placebo in adults with obesity and type 2 diabetes.
Limitations
Small phase 2 sample|Specific diabetes population|Intravenous monoclonal antibody|Not a peptide